The new report on Global Cardiac Rhythm Management Devices Market published by Absolute Markets Insights offers in-depth coverage of the industry and important Market trends with historical and forecast Market information, demand, application information, price development and shares from the leading Cardiac Rhythm Management Devices company by geography. This report also studies Cardiac Rhythm Management Devices Market status, competitive landscape, Market share, growth rate, future trends, Marketers, opportunities and challenges, sales channels and distributors. The report breaks down Market size by volume and value based on application, type and geography.

Top Key Players includes: Siemens AG, 3M Company (3M), Abiomed, Inc.(ABIOMED), Berlin Heart GmbH (Berlin Heart), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, General Electric Company (General Electric), Hill-Rom Services Inc., Jarvik Heart, Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic, NIHON KOHDEN CORPORATION, and ZOLL Medical Corporation amongst others.

Cardiac Rhythm Management Devices Market is expected to grow with a CAGR of +6.5% during the forecast period of 2020 to 2030. The study analyzes the market in terms of revenue and sales volume across all the major markets.

For More Information [email protected]

Cardiac Rhythm Management Devices Market, by Product

Pacemakers (PM) are among the most commonly used cardiac rhythm management devices, which give electrical impulses to trigger the heartbeat when it is slow or stops altogether. An Implantable Cardioverter Defibrillator (ICD) automatically delivers a shock to restore the normal rhythm by detecting fast or chaotic beating of heart’s main pumping chamber, which often leads to sudden cardiac arrests. Most cardiac rhythm management devices also act as pacemakers and both these devices provide constant care to patients with irregular heart rhythms.

Cardiac Rhythm Management Devices Market, by Region

The significant presence of population requiring cardiac rhythm management therapy, due to the prevalence of serious risk factors such as diabetes, hypertension, obesity, and congestive heart failure across regions is influencing the demand of CRMDs in this market. Boston Scientific is a medical device manufacturer based in Marlborough, Massachusets, US, which markets a wide range of CRM devices. It is among the leading manufacturers of these products including RHYTHMIA HDx Mapping System that enables physicians to provide personalized care to patients suffering from arrhythmias. Biotronik is a company headquartered in Berlin, Germany and is gaining popularity for their CRT pacemaker with remote monitoring called Etrinsa 8 HF-T. The availability of such devices in the market catering to the specific requirements of cardiac patients is substantially improving cardiac care standards.

Cardiac Rhythm Management Devices Market Segmentation:

By Product

  • Pacemakers
    • Implantable Pacemakers
    • External Pacemakers
  • Defibrillators
  • Implantable Cardioverter Defibrillators (ICDs)
    • Subcutaneous ICD (S-ICD)
    • Transvenous ICD (T-ICD)
  • External Defibrillator (ED)
    • Manual ED
    • Automated ED (AED)
    • Wearable Cardioverter Defibrillator
  • Cardiac Resynchronization Therapy (CRT)
    • CRT Defibrillators (CRT-D)
    • CRT Pacemakers (CRT-P)

By End User

  • Hospitals and Clinics
  • Home Settings
  • Ambulatory Service Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Contact Us:
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +917400242424 , US +1-510-420-1213
Contact Name: Shreyas Tanna